rofecoxib has been researched along with Deficiency, Vitamin D in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vitamin D deficiency is common in chronic kidney disease (CKD)." | 1.38 | Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease. ( de Borst, MH; de Cuba, MM; Doorenbos, CR; Gans, RO; Kema, IP; Navis, G; van den Born, J; Vogt, L, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doorenbos, CR | 1 |
| de Cuba, MM | 1 |
| Vogt, L | 1 |
| Kema, IP | 1 |
| van den Born, J | 1 |
| Gans, RO | 1 |
| Navis, G | 1 |
| de Borst, MH | 1 |
1 other study available for rofecoxib and Deficiency, Vitamin D
| Article | Year |
|---|---|
Antiproteinuric treatment reduces urinary loss of vitamin D-binding protein but does not affect vitamin D status in patients with chronic kidney disease.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Comb | 2012 |